VAERS reports by lot

Moderna COVID-19 lot 058A22-2A: VAERS reports

727 VAERS reports list lot 058A22-2A as a Moderna COVID-19 vaccine, received between 2022-06-01 and 2024-07-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
727
Reports
3%
Marked serious
3
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)7821%
Neurological5214%
Cardiac / Cardiovascular5114%
Gastrointestinal5014%
Injection-site / Local reaction4713%
Musculoskeletal226%
Respiratory185%
Allergic / Anaphylactic175%
Dermatological (non-injection-site)134%
Psychiatric / Neuropsychiatric103%
Thrombotic / Hematological41%
Autoimmune / Immune-mediated31%

Where reports came from

U.S. state of the reporter, where given (top 12).

Arizona542
New Jersey22
North Carolina21
Michigan14
Colorado13
Virginia9
California8
Ohio7
Illinois6
Massachusetts5
New York5
Connecticut5

Reports by month received

2022-0656
2022-0751
2022-08550
2022-098
2022-102
2022-115
2022-1239
2023-017
2023-021
2023-041
2023-051
2023-063
2023-072
2024-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.